Filter
122
Filtered Results: 122
Text search:
bromine
Featured
Recommendations
22
New Publications
35
Language
Document type
No document type
55
Guidelines
36
Studies & Reports
15
Manuals
8
Fact sheets
3
Training Material
2
Strategic & Response Plan
2
Infographics
1
Countries / Regions
Kenya
7
South Africa
7
Ethiopia
7
Philippines
6
India
6
Nepal
4
Global
4
Congo, Democratic Republic of
4
Rwanda
3
Syria
3
Uganda
3
Myanmar / Burma
3
Ghana
2
Nigeria
2
USA
2
Western and Central Europe
2
Zambia
2
Indonesia
2
Eswatini/ Swaziland
2
Benin
1
Fiji
1
Senegal
1
Africa
1
Spain
1
Brazil
1
Namibia
1
Angola
1
Libya
1
Bhutan
1
Botswana
1
South Sudan
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
64
Clinical Guidelines
16
Public Health
7
Pharmacy & Technologies
5
Key Resources
2
Women & Child Health
1
Toolboxes
Pharmacy
23
Specific Hazards
9
NCDs
8
Planetary Health
5
Caregiver
4
NTDs
4
Conflict
4
Rapid Response
2
Mental Health
2
Natural Hazards
2
HIV
2
COVID-19
2
AMR
2
TB
1
Ebola & Marburg
1
Global Health Education
1
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid...
Asthma prevalence is increasing worldwide and surveys indicate that the majority of patients in developed and developing countries do not receive optimal care and are therefore not well controlled. The aim of these guidelines is to promote a better standard of treatment based on advances in the unde...
This report reviews the current situation in relation to national capacity to address NCDs and the progress made at country level over the past decade. It highlights that, while progress is being made, there is still much work to be done to create the infrastructure, policies, surveillance and healt...
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
The potential for terrorist use of chemical agents is a noted concern highlighted by the Tokyo sarin gas attacks of 1995. The events of September 11, 2001, increased congressional attention towards reducing the vulnerability of the United States to such unconventional attacks. The
possibility that...
24 May 2021; Guidance for vaccinators on how to store, prepare, draw up and administer COVID-19 vaccines Updated May 2021 · Western Cape Edition
Practical Approach to Care Kit: Vaccine
Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
Essential Medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy, safety and comparative cost-effectiveness. This edition of the Essential Medicines List (EML) 2017 for Ghana has been deriv...
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire population of Uganda, as a means of providing satisfactory health care and safeguarding the appropriate us...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
Rapid review and case studies from Member States
6th edition, The NLEM 2021 contains 398 drugs molecules in different therapeutic categories.
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
